Done sou Salè H1B

Akèy › Kat vèt › Otsuka America Pharmaceutical, Inc.

Otsuka America Pharmaceutical, Inc.: sponso kat vèt (PERM)

Otsuka America Pharmaceutical, Inc. te depoze 3 aplikasyon sètifikasyon travay PERM ki te pran desizyon pandan ane fiskal 2024–2026; sètifye: 3. Mwayèn salè yo ofri $226,034; mwayèn tan soti nan depozisyon jiska sètifikasyon: 495 jou.

Aplikasyon PERM3
Sètifye3
Salè medyan ofri$226,034
Mwayèn jou pou sètifikasyon495
Deja ap travay pou anplwayè a100%
Anplwaye (jan yo depoze)1,302
Nan biznis depi1989
Adrès anplwayèPrinceton, NJ

Salè H-1B nan Otsuka America Pharmaceutical, Inc. →

Tit travay

Tit travayAplikasyon PERMSalè medyan
Senior Director, Business Planning and Development1$235,000
Senior Manager, Cloud Infrastructure Engineer1$160,000
Associate Director, Senior IT Business Partner (Tech Ops)1$226,034

Kote travay

Okipasyon

Dènye desizyon

Tit travaySalè bazKoteSoumètDesideEstatiJou
Associate Director, Senior IT Business Partner (Tech Ops)$226,034–$230,000Aliso Viejo, CANov 11, 2024Mar 26, 2026Sètifye500
Senior Director, Business Planning and Development$235,000–$250,000Princeton, NJMay 1, 2024Aug 22, 2025Sètifye478
Senior Manager, Cloud Infrastructure Engineer$160,000–$180,000San Francisco, CAOct 12, 2023Feb 18, 2025Sètifye, ekspiré495

Salè yo se pi ba nivo salè yo ofri nan chak aplikasyon, konvèti an yon montan anyèl; estatistik yo itilize aplikasyon plen tan ki sètifye. Sètifikasyon PERM se yon etap nan direksyon yon kat vèt; USCIS pran desizyon sou petisyon an. Se pa konsèy legal. Sous: Depatman Travay Etazini, Done Divilgasyon OFLC PERM, ane fiskal 2024–2026 (dènye desizyon Jun 30, 2026).